NCT05863910 Real World Evidence on the Use of Medical Cannabis in Pediatrics
| NCT ID | NCT05863910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-11-20 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
Eligibility Criteria
Inclusion Criteria: * 3 to 17 years * have a medical document provided by a prescribing health care practitioner (i.e. physician, nurse practitioner, etc.) for the use of medical cannabis * medical cannabis is authorized for pain, sleep, mood, behaviour, seizures, cancer or cancer-treatment related symptom management * ability to respond to electronic questionnaires in English Exclusion Criteria: * individuals using cannabis for medical purposes without a medical cannabis authorization from a health care provider * those only using cannabis recreationally
Contact & Investigator
Sapna Oberoi, MD
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT05863910 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 17 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05863910 currently recruiting?
Yes, NCT05863910 is actively recruiting participants. Contact the research team at lauren.kelly@umanitoba.ca for enrollment information.
Where is the NCT05863910 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT05863910 clinical trial?
NCT05863910 is sponsored by University of Manitoba. The principal investigator is Sapna Oberoi, MD at University of Manitoba. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.